Checkpoint Inhibitors Hodgkin Lymphoma and Non-Hodgkin Lymphoma

Hu, B; Jacobs, R; Ghosh, N

Ghosh, N (reprint author), Levine Canc Inst, Dept Hematol Malignancies & Blood Disorders, Atrium Hlth, Charlotte, NC 28204 USA.

CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2018; 13 (6): 543

Abstract

Purpose of the ReviewThe ligation of PD-1 with PD-L1 activates a critical immune checkpoint leading to T cell dysfunction, exhaustion, and tolerance. ......

Full Text Link